PLRX - Pliant Therapeutics Inc
1.33
-0.060 -4.511%
Share volume: 289,680
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.39
-0.06
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-07-2024 | 11-07-2024 | 03-03-2025 | 05-08-2025 | 11-06-2025 | |
| Cash flow financing | 21.788 M | 684.000 K | 543.000 K | 102.000 K | 498.000 K | 72.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -30.271 M | -33.911 M | -770.000 K | -8.428 M | 20.748 M | 6.912 M | |
| Net income | -46.955 M | -55.854 M | -57.763 M | -49.732 M | -56.166 M | -26.301 M | |
| Depreciation | 513.000 K | 622.000 K | 532.000 K | 458.000 K | 448.000 K | 436.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 59.546 M | 10.702 M | 30.960 M | 39.132 M | 69.114 M | 27.921 M | |
| Net Borrowings | -435.243 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.492 M | 1.251 M | 896.000 K | 209.000 K | 262.000 K | 0.000 | |
| Cash Change | 482.389 M | -33.911 M | -770.000 K | -8.428 M | 20.748 M | 6.912 M |